Published in Cancer Weekly, December 24th, 2002
Regence, through its Blue Cross and Blue Shield affiliates in Oregon, Washington, Utah, and Idaho provide healthcare coverage to more than 3 million members.
Regence will offer capsule endoscopy reimbursement to those among its beneficiaries who may suffer from disorders associated with gastrointestinal bleeding from sources unidentified by other diagnostic methods. This brings to 38 million the total number of patients in the United States who currently have reimbursable access to the M2A diagnostic system...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.